NIH Guide: Weekly Index for February 21, 2020

Funding Opportunities

• Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
  (PAR-20-112)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): June 1, 2020
• Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
  (PAR-20-113)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 1, 2020
• High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
  (PAR-20-114)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  National Institute of General Medical Sciences
  Application Receipt Date(s): June 1, 2020
• Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
  (PAR-20-115)
  National Institute of General Medical Sciences
  Application Receipt Date(s): May 28, 2020; May 28, 2021; and May 27, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Prodromal -Synucleinopathies Consortium (PSS) (U19 Clinical Trial Optional)
  (RFA-AG-21-013)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): June 17, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.
• Network for Identification, Evaluation, and Tracking of Older Persons with Superior Cognitive Performance for Their Chronological Age (U19 Clinical Trial Not Allowed)
  (RFA-AG-21-015)
  National Institute on Aging
  Application Receipt Date(s): October 1, 2020 All applications are due by 5:00 PM local time of applicant organization.All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
• Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
  (RFA-AI-20-021)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): April 14, 2020
• Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required)
  (RFA-DA-20-028)
  National Institute on Drug Abuse
  Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below
• FDA's National Curriculum Standard Development and Training Delivery and Development (U18) Clinical Trial Not Allowed FDA's National Curriculum Standard Development and Training Delivery and Development (U18) Clinical Trial Not Allowed
  (RFA-FD-20-024)
  Food and Drug Administration
  Application Receipt Date(s): April 28, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed
  (RFA-FD-20-027)
  Food and Drug Administration
  Application Receipt Date(s): April 22, 2020 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required
  (RFA-FD-21-001)
  Food and Drug Administration
  Application Receipt Date(s): October 6, 2020, October 5, 2021; by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
• Training Modules to Enhance the Rigor, Reproducibility and Responsible Conduct of Biomedical Data Science Research (R25 - Clinical Trial Not Allowed)
  (RFA-GM-20-001)
  National Institute of General Medical Sciences
  National Institute of Allergy and Infectious Diseases
  National Institute of Dental and Craniofacial Research
  National Library of Medicine
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): June 19, 2020 by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Supporting Primary Care to Advance Cardiovascular Health in States with High Prevalence of Preventable CVD Events (U18)
  (RFA-HS-20-002)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): May 22, 2020 by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. No late applications will be accepted for this Funding Opportunity Announcement.